TY - JOUR
T1 - Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects
AU - Gelber, David A.
AU - Pfeifer, Michael A.
AU - Broadstone, Vasti L.
AU - Munster, Edward W.
AU - Peterson, Michael
AU - Arezzo, Joseph C.
AU - Shamoon, Harry
AU - Zeidler, Adina
AU - Clements, Rex
AU - Greene, Douglas A.
AU - Porte, Daniel
AU - Laudadio, Charles
AU - Bril, Vera
N1 - Copyright:
Copyright 2015 Elsevier B.V., All rights reserved.
PY - 1995
Y1 - 1995
N2 - Quantitative sensory testing (QST) is commonly used in the assessment of diabetic neuropathy. However, little data are available on the reliability of tactile and thermal testing devices. Reproducibility of QST measures between centers has not been previously reported. This study was designed to validate QST testing procedures and determine if these devices are suitable for large scale multicenter clinical trials. Finger and toe vibratory (Vf, Vt) and thermal (Tf, Tt) thresholds were determined for ten normal individuals by a two-alternative forced-choice procedure using the Optacon Tactile Tester (OTT) and Thermal Sensitivity Tester (TST). Threshold measurements were reproducible between technologists and had a day-to-day coefficient of variation of Vf 20%, Vt 23%, Tf 41%, and Tt 95%. Thresholds were determined for 140 normal individuals at six centers. Mean threshold values between centers were not significantly different. Center-to-center coefficents of variation (CV) were Vf 44%, Vt 45%, Tf 47%, and Tt 87%. There was no significant difference in threshold measures with regard to sex, side studied, presence of calluses, or skin temperature. Vf thresholds significantly correlated with age (p < 0.01). There was no correlation between either vibratory or thermal thresholds in normal individuals, and nerve conduction velocities (NCV). Thermal and vibratory thresholds were determined for 98 diabetic patients. Diabetic subjects without clinical evidence of neuropathy were not significantly different from normal individuals, but diabetic patients with neuropathy had increased thresholds compared to normals (p < 0.05). We conclude that thermal and vibratory threshold testing with the OTT and TST yields reproducible measurements in normal individuals and provides an objective measure of clinical diabetic neuropathy that is well suited for multicenter trials.
AB - Quantitative sensory testing (QST) is commonly used in the assessment of diabetic neuropathy. However, little data are available on the reliability of tactile and thermal testing devices. Reproducibility of QST measures between centers has not been previously reported. This study was designed to validate QST testing procedures and determine if these devices are suitable for large scale multicenter clinical trials. Finger and toe vibratory (Vf, Vt) and thermal (Tf, Tt) thresholds were determined for ten normal individuals by a two-alternative forced-choice procedure using the Optacon Tactile Tester (OTT) and Thermal Sensitivity Tester (TST). Threshold measurements were reproducible between technologists and had a day-to-day coefficient of variation of Vf 20%, Vt 23%, Tf 41%, and Tt 95%. Thresholds were determined for 140 normal individuals at six centers. Mean threshold values between centers were not significantly different. Center-to-center coefficents of variation (CV) were Vf 44%, Vt 45%, Tf 47%, and Tt 87%. There was no significant difference in threshold measures with regard to sex, side studied, presence of calluses, or skin temperature. Vf thresholds significantly correlated with age (p < 0.01). There was no correlation between either vibratory or thermal thresholds in normal individuals, and nerve conduction velocities (NCV). Thermal and vibratory thresholds were determined for 98 diabetic patients. Diabetic subjects without clinical evidence of neuropathy were not significantly different from normal individuals, but diabetic patients with neuropathy had increased thresholds compared to normals (p < 0.05). We conclude that thermal and vibratory threshold testing with the OTT and TST yields reproducible measurements in normal individuals and provides an objective measure of clinical diabetic neuropathy that is well suited for multicenter trials.
UR - http://www.scopus.com/inward/record.url?scp=0029047183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029047183&partnerID=8YFLogxK
U2 - 10.1016/1056-8727(94)00042-M
DO - 10.1016/1056-8727(94)00042-M
M3 - Article
C2 - 7548981
AN - SCOPUS:0029047183
SN - 1056-8727
VL - 9
SP - 170
EP - 176
JO - Journal of Diabetes and its Complications
JF - Journal of Diabetes and its Complications
IS - 3
ER -